VCAM1 and atherosclerosis: A number of specific targeted ultrasound probes has been tested in vivo for assessing biomarkers such as VCAM-1 [217,218,219], P-selectin [220] and von Willebrand factor [221,222] in genetically modified mouse models of atherosclerosis (as shown in Figure 5).